FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117001736> ?p ?o ?g. }

• W2117001736 endingPage "18B" @default.
• W2117001736 startingPage "18B" @default.
• W2117001736 abstract "Back to table of contents Previous article Next article Clinical & Research NewsFull AccessCognitive Therapy Helps Patients With SchizophreniaMark MoranMark MoranSearch for more papers by this authorPublished Online:18 Nov 2011https://doi.org/10.1176/pn.46.22.psychnews_46_22_18_2AbstractCognitive therapy can be successful in promoting clinically meaningful improvements in functional outcome, motivation, and positive symptoms in low-functioning schizophrenia patients with significant cognitive impairment. That was the finding from a randomized trial to evaluate the efficacy of an 18-month recovery-oriented cognitive-therapy program to improve psychosocial functioning and negative symptoms of avolition-apathy and anhedonia-asociality in patients with schizophrenia. A report on the findings appears in the October Archives of General Psychiatry.The message for clinicians is, 'Don't give up on these low-functioning patients,' lead author Paul Grant, Ph.D., of the University of Pennsylvania School of Medicine, told Psychiatric News . They have hidden potential. Despite a long course of disorder, we have seen that these patients can improve and achieve their goals and develop a better quality of life. Sixty participants were randomly assigned to the study intervention condition, which consisted of cognitive therapy plus standard treatment, or to the control condition of standard treatment alone. (Randomization was stratified by sex because females with schizophrenia have a better course and may respond better to cognitive therapy.)A single-blind design was used in which outcome assessors were not aware of assigned study condition.Participants in the cognitive-therapy intervention received up to 18 months of outpatient sessions. The sessions typically lasted 50 minutes and were scheduled on a weekly basis. The central features of this psychotherapy were its goal-directed framework and personalized treatment planning.As described by Grant in a presentation at this year's International Congress of Schizophrenia Research, the intervention is a form of therapy developed especially for schizophrenia patients by Aaron Beck, M.D., the primary developer of cognitive therapy (Psychiatric News, May 20).Specific deficiencies such as deficits in attention, executive function, and social skills were targets for the therapy. Later sessions were devoted to relapse prevention and consolidation of functional gains. The treatment was tailored to the participant's level of functioning, such that special adaptations were made for problems due to poor engagement, neurocognitive impairment, thought disorder, or lack of insight. Standard treatment consisted, at a minimum, of antipsychotic pharmacotherapy. But most participants were also actively engaged in services provided by local community mental health centers, including case management, supportive counseling, day-treatment services, housing services, peer support, and vocational rehabilitation, the researchers noted.Results showed that patients treated with cognitive therapy showed a clinically significant mean improvement in global functioning from baseline to 18 months that was greater than the improvement seen with standard treatment. Patients receiving cognitive therapy also showed a greater mean reduction in avolition-apathy and positive symptoms (hallucinations, delusions, disorganization). There were no meaningful group differences in baseline antipsychotic medications (class or dosage) or in medication changes during the trial.Traditionally, negative symptoms in low-functioning patients have been viewed as deeply embedded, possibly reflecting a neurobiological deficit in the most severe cases designated as deficit syndrome. Grant told Psychiatric News that the study did not specifically recruit patients designated as having deficit syndrome, but said the study results indicate that severe negative symptoms can respond to psychosocial therapy. The trial provides evidence that these low-functioning patients respond to psychosocial treatment, suggesting that their symptoms are not as entrenched as one might have expected based upon case histories and the literature on such patients, he said. A treatment protocol with psychological targets, such as defeatist beliefs, works in this population, indicating they are like other patients and warrant a biopsychosocial formulation. Randomized Trial to Evaluate the Efficacy of Cognitive Therapy for Low-Functioning Patients With Schizophrenia is posted at < http://archpsyc.ama-assn.org/cgi/content/full/archgenpsychiatry.2011.129>. ISSUES NewArchived" @default.
• W2117001736 created "2016-06-24" @default.
• W2117001736 creator A5089844398 @default.
• W2117001736 date "2011-11-18" @default.
• W2117001736 modified "2023-09-25" @default.
• W2117001736 title "Cognitive Therapy Helps Patients With Schizophrenia" @default.
• W2117001736 doi "https://doi.org/10.1176/pn.46.22.psychnews_46_22_18_2" @default.
• W2117001736 hasPublicationYear "2011" @default.
• W2117001736 type Work @default.
• W2117001736 sameAs 2117001736 @default.
• W2117001736 citedByCount "0" @default.
• W2117001736 crossrefType "journal-article" @default.
• W2117001736 hasAuthorship W2117001736A5089844398 @default.
• W2117001736 hasConcept C118552586 @default.
• W2117001736 hasConcept C126322002 @default.
• W2117001736 hasConcept C150966472 @default.
• W2117001736 hasConcept C15744967 @default.
• W2117001736 hasConcept C168563851 @default.
• W2117001736 hasConcept C169900460 @default.
• W2117001736 hasConcept C2776412080 @default.
• W2117001736 hasConcept C2776509080 @default.
• W2117001736 hasConcept C2778941446 @default.
• W2117001736 hasConcept C2779477915 @default.
• W2117001736 hasConcept C2779951463 @default.
• W2117001736 hasConcept C2780665704 @default.
• W2117001736 hasConcept C542102704 @default.
• W2117001736 hasConcept C63529061 @default.
• W2117001736 hasConcept C70410870 @default.
• W2117001736 hasConcept C71924100 @default.
• W2117001736 hasConceptScore W2117001736C118552586 @default.
• W2117001736 hasConceptScore W2117001736C126322002 @default.
• W2117001736 hasConceptScore W2117001736C150966472 @default.
• W2117001736 hasConceptScore W2117001736C15744967 @default.
• W2117001736 hasConceptScore W2117001736C168563851 @default.
• W2117001736 hasConceptScore W2117001736C169900460 @default.
• W2117001736 hasConceptScore W2117001736C2776412080 @default.
• W2117001736 hasConceptScore W2117001736C2776509080 @default.
• W2117001736 hasConceptScore W2117001736C2778941446 @default.
• W2117001736 hasConceptScore W2117001736C2779477915 @default.
• W2117001736 hasConceptScore W2117001736C2779951463 @default.
• W2117001736 hasConceptScore W2117001736C2780665704 @default.
• W2117001736 hasConceptScore W2117001736C542102704 @default.
• W2117001736 hasConceptScore W2117001736C63529061 @default.
• W2117001736 hasConceptScore W2117001736C70410870 @default.
• W2117001736 hasConceptScore W2117001736C71924100 @default.
• W2117001736 hasIssue "22" @default.
• W2117001736 hasLocation W21170017361 @default.
• W2117001736 hasOpenAccess W2117001736 @default.
• W2117001736 hasPrimaryLocation W21170017361 @default.
• W2117001736 hasRelatedWork W1859768362 @default.
• W2117001736 hasRelatedWork W1972099588 @default.
• W2117001736 hasRelatedWork W1990992013 @default.
• W2117001736 hasRelatedWork W2126574564 @default.
• W2117001736 hasRelatedWork W2367257246 @default.
• W2117001736 hasRelatedWork W2367277681 @default.
• W2117001736 hasRelatedWork W2769467664 @default.
• W2117001736 hasRelatedWork W3029200474 @default.
• W2117001736 hasRelatedWork W3136874253 @default.
• W2117001736 hasRelatedWork W4323666504 @default.
• W2117001736 hasVolume "46" @default.
• W2117001736 isParatext "false" @default.
• W2117001736 isRetracted "false" @default.
• W2117001736 magId "2117001736" @default.
• W2117001736 workType "article" @default.